Literature DB >> 23946416

Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.

Jennifer L Whitwell1, Val J Lowe, Joseph R Duffy, Edythe A Strand, Mary M Machulda, Kejal Kantarci, Samantha M Wille, Matthew L Senjem, Matthew C Murphy, Jeffrey L Gunter, Clifford R Jack, Keith A Josephs.   

Abstract

BACKGROUND: Most subjects with logopenic variant of primary progressive aphasia (lvPPA) have β-amyloid (Aβ) deposition on Pittsburgh Compound B positron emission tomography (PiB-PET), usually affecting prefrontal and temporoparietal cortices, with less occipital involvement.
OBJECTIVES: To assess clinical and imaging features in lvPPA subjects with unusual topographic patterns of Aβ deposition with highest uptake in occipital lobe.
METHODS: Thirty-three lvPPA subjects with Aβ deposition on PiB-PET were included in this case-control study. Line plots of regional PiB uptake were created, including frontal, temporal, parietal and occipital regions, for each subject. Subjects in which the line sloped downwards in occipital lobe (lvPPA-low), representing low uptake, were separated from those where the line sloped upwards in occipital lobe (lvPPA-high), representing unusually high occipital uptake compared to other regions. Clinical variables, atrophy on MRI, hypometabolism on 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and presence and distribution of microbleeds and white matter hyperintensities (WMHs) were assessed.
RESULTS: Seventeen subjects (52%) were classified as lvPPA-high. Mean occipital PiB uptake in lvPPA-high was higher than all other regions and higher than all regions in lvPPA-low. The lvPPA-high subjects performed more poorly on cognitive testing, including executive and visuospatial testing, but the two groups did not differ in aphasia severity. Proportion of microbleeds and WMH was higher in lvPPA-high than lvPPA-low. Parietal hypometabolism was greater in lvPPA-high than lvPPA-low.
CONCLUSIONS: Unusually high occipital Aβ deposition is associated with widespread cognitive impairment and different imaging findings in lvPPA. These findings help explain clinical heterogeneity in lvPPA and suggest that Aβ influences severity of overall cognitive impairment but not aphasia.

Entities:  

Keywords:  Alzheimer'S Disease; Amyloid; Aphasia; Cognition; Neuroradiology

Mesh:

Substances:

Year:  2013        PMID: 23946416      PMCID: PMC3920541          DOI: 10.1136/jnnp-2013-305628

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  Mayo's Older Americans Normative Studies: Age- and IQ-Adjusted Norms for the Auditory Verbal Learning Test and the Visual Spatial Learning Test.

Authors:  Brett A Steinberg; Linas A Bieliauskas; Glenn E Smith; Robert J Ivnik; James F Malec
Journal:  Clin Neuropsychol       Date:  2005 Sep-Dec       Impact factor: 3.535

2.  Mayo's Older Americans Normative Studies: Age- and IQ-Adjusted Norms for the Trail-Making Test, the Stroop Test, and MAE Controlled Oral Word Association Test.

Authors:  Brett A Steinberg; Linas A Bieliauskas; Glenn E Smith; Robert J Ivnik
Journal:  Clin Neuropsychol       Date:  2005 Sep-Dec       Impact factor: 3.535

3.  Microbleeds in the logopenic variant of primary progressive aphasia.

Authors:  Jennifer L Whitwell; Clifford R Jack; Joseph R Duffy; Edythe A Strand; Jeffrey L Gunter; Matthew L Senjem; Matthew C Murphy; Kejal Kantarci; Mary M Machulda; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2013-04-03       Impact factor: 21.566

4.  Basic visual function and cortical thickness patterns in posterior cortical atrophy.

Authors:  Manja Lehmann; Josephine Barnes; Gerard R Ridgway; John Wattam-Bell; Elizabeth K Warrington; Nick C Fox; Sebastian J Crutch
Journal:  Cereb Cortex       Date:  2011-02-10       Impact factor: 5.357

Review 5.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

6.  An empirically derived short form of the Boston naming test.

Authors:  A E Lansing; R J Ivnik; C M Cullum; C Randolph
Journal:  Arch Clin Neuropsychol       Date:  1999-08       Impact factor: 2.813

7.  Prediction of pathology in primary progressive language and speech disorders.

Authors:  V Deramecourt; F Lebert; B Debachy; M A Mackowiak-Cordoliani; S Bombois; O Kerdraon; L Buée; C-A Maurage; F Pasquier
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

8.  Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.

Authors:  K A Josephs; J L Whitwell; J R Duffy; W A Vanvoorst; E A Strand; W T Hu; B F Boeve; N R Graff-Radford; J E Parisi; D S Knopman; D W Dickson; C R Jack; R C Petersen
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

9.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  FLAIR histogram segmentation for measurement of leukoaraiosis volume.

Authors:  C R Jack; P C O'Brien; D W Rettman; M M Shiung; Y Xu; R Muthupillai; A Manduca; R Avula; B J Erickson
Journal:  J Magn Reson Imaging       Date:  2001-12       Impact factor: 4.813

View more
  17 in total

Review 1.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

2.  Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; María Valles-Salgado; Marta Fernandez-Matarrubia; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

Review 3.  Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy.

Authors:  Carolyn Akers; Lealani May Y Acosta; Ciaran Considine; Daniel Claassen; Howard Kirshner; Matthew Schrag
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

4.  Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.

Authors:  William C Kreisl; Chul Hyoung Lyoo; Jeih-San Liow; Joseph Snow; Emily Page; Kimberly J Jenko; Cheryl L Morse; Sami S Zoghbi; Victor W Pike; R Scott Turner; Robert B Innis
Journal:  Neurobiol Aging       Date:  2016-12-16       Impact factor: 4.673

5.  APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Alzheimers Dement       Date:  2014-06-28       Impact factor: 21.566

6.  Regional β-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia.

Authors:  Y Jung; J L Whitwell; J R Duffy; E A Strand; M M Machulda; M L Senjem; C R Jack; V J Lowe; K A Josephs
Journal:  Eur J Neurol       Date:  2015-06-23       Impact factor: 6.089

Review 7.  Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.

Authors:  Alberto Villarejo-Galende; Sara Llamas-Velasco; Adolfo Gómez-Grande; Verónica Puertas-Martín; Israel Contador; Pilar Sarandeses; Marta González-Sánchez; Rocío Trincado; Patrick Pilkington; Sebastián Ruiz-Solis; David A Pérez-Martínez; Alejandro Herrero-San Martín
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

8.  Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Authors:  Irene Sintini; Christopher G Schwarz; Peter R Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Daniel A Drubach; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell
Journal:  Hum Brain Mapp       Date:  2018-12-13       Impact factor: 5.038

9.  Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.

Authors:  Jennifer L Whitwell; Kejal Kantarci; Stephen D Weigand; Emily S Lundt; Jeffrey L Gunter; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Anthony J Spychalla; Daniel A Drubach; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  Periventricular hyperintensities are associated with elevated cerebral amyloid.

Authors:  Michael Marnane; Osama O Al-Jawadi; Shervin Mortazavi; Kathleen J Pogorzelec; Bing Wei Wang; Howard H Feldman; Ging-Yuek R Hsiung
Journal:  Neurology       Date:  2016-01-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.